Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
40
Frequently Asked Questions
What is Market Cap of Mateon Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Mateon Therapeutics Inc market cap is $21.62M.
What is the 52-week high for Mateon Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Mateon Therapeutics Inc 52 week high is $0.07 as of September 13, 2025.
What is the 52-week low for Mateon Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mateon Therapeutics Inc 52 week low is $0.017 as of September 13, 2025.
What is Mateon Therapeutics Inc stock price today?
Mateon Therapeutics Inc stock price today is $0.26.
What was Mateon Therapeutics Inc stock price yesterday?
Mateon Therapeutics Inc stock price yesterday was $0.24.
What is the PE ratio of Mateon Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Mateon Therapeutics Inc’s P/E ratio is -5.12.
What is the Price-to-Book ratio of Mateon Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Mateon Therapeutics Inc P/B ratio is 2.4447.
What is the 50-day moving average of Mateon Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Mateon Therapeutics Inc 50-day moving average is $0.0503.
How many employess does Mateon Therapeutics Inc has?